Reduction in recurrent MACE in patients with CHD. Results of the Neptuno substudy.

8 April 2022 (16:25 - 16:40)
Organised by:
Congress Presentation Part of: Managing atherosclerotic cardiovascular disease (ASCVD) patients: polypill strategy as baseline treatment Cardiovascular Pharmacotherapy Open Access ESC Preventive Cardiology 2022

ESC 365 is supported by

ESC 365 is supported by